Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Blutzucker

The query asks for an evidence check on a 'Cardio Risk Check' in the context of blood sugar. The provided knowledge contexts contain no specific information about such a test from MyBody-X. Blood sugar (especially fasting glucose, HbA1c) is a well-established cardiovascular risk factor used in clinical scores like PROCAM or SCORE. A direct DNA test for blood sugar-related genes (e.g., TCF7L2, GCKR) can theoretically indicate genetic predisposition, but its predictive power for individual cardiovascular risk is weak and heavily modulated by lifestyle. Without specific studies or product details, the evidence for a combined test integrating genetic markers and blood sugar is unclear. MyBody-X may offer such analyses, but validity must be assessed through independent clinical trials. Caveat: Not a substitute for medical risk assessment; blood sugar measurements should be standardized.